Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 845 entries
Sorted by: Best Match Show Resources per page
Catechin and epicatechin reduce mitochondrial dysfunction and oxidative stress induced by amiodarone in human lung fibroblasts.

Journal of arrhythmia

Silva Santos LF, Stolfo A, Calloni C, Salvador M.
PMID: 28607618
J Arrhythm. 2017 Jun;33(3):220-225. doi: 10.1016/j.joa.2016.09.004. Epub 2016 Oct 22.

BACKGROUND: Amiodarone (AMD) and its metabolite N-desethylamiodarone can cause some adverse effects, which include pulmonary toxicity. Some studies suggest that mitochondrial dysfunction and oxidative stress may play a role in these adverse effects. Catechin and epicatechin are recognized as...

Cite
Silva Santos LF, Stolfo A, Calloni C, et al. Catechin and epicatechin reduce mitochondrial dysfunction and oxidative stress induced by amiodarone in human lung fibroblasts. J Arrhythm. 2016;33(3):220-225doi: 10.1016/j.joa.2016.09.004.
Silva Santos, L. F., Stolfo, A., Calloni, C., & Salvador, M. (2017). Catechin and epicatechin reduce mitochondrial dysfunction and oxidative stress induced by amiodarone in human lung fibroblasts. Journal of arrhythmia, 33(3), 220-225. https://doi.org/10.1016/j.joa.2016.09.004
Silva Santos, Luciana Fernandes, et al. "Catechin and epicatechin reduce mitochondrial dysfunction and oxidative stress induced by amiodarone in human lung fibroblasts." Journal of arrhythmia vol. 33,3 (2017): 220-225. doi: https://doi.org/10.1016/j.joa.2016.09.004
Silva Santos LF, Stolfo A, Calloni C, Salvador M. Catechin and epicatechin reduce mitochondrial dysfunction and oxidative stress induced by amiodarone in human lung fibroblasts. J Arrhythm. 2017 Jun;33(3):220-225. doi: 10.1016/j.joa.2016.09.004. Epub 2016 Oct 22. PMID: 28607618; PMCID: PMC5459414.
Copy Download .nbib Format: NLM
Effect of stem cell therapy on amiodarone induced fibrosing interstitial lung disease in albino rat.

International journal of stem cells

Zaglool SS, Zickri MB, Abd El Aziz DH, Mabrouk D, Metwally HG.
PMID: 24298346
Int J Stem Cells. 2011 Nov;4(2):133-42. doi: 10.15283/ijsc.2011.4.2.133.

BACKGROUND AND OBJECTIVES: The fibrosing forms of interstitial lung disease (ILD) are associated with significant morbidity and mortality. ILD may be idiopathic, secondary to occupational, infection, complicate rheumatic diseases or drug induced. Efficacy of antifibrotic agents is as far...

Cite
Zaglool SS, Zickri MB, Abd El Aziz DH, et al. Effect of stem cell therapy on amiodarone induced fibrosing interstitial lung disease in albino rat. Int J Stem Cells. 2011;4(2):133-42doi: 10.15283/ijsc.2011.4.2.133.
Zaglool, S. S., Zickri, M. B., Abd El Aziz, D. H., Mabrouk, D., & Metwally, H. G. (2011). Effect of stem cell therapy on amiodarone induced fibrosing interstitial lung disease in albino rat. International journal of stem cells, 4(2), 133-42. https://doi.org/10.15283/ijsc.2011.4.2.133
Zaglool, Somaya Saad, et al. "Effect of stem cell therapy on amiodarone induced fibrosing interstitial lung disease in albino rat." International journal of stem cells vol. 4,2 (2011): 133-42. doi: https://doi.org/10.15283/ijsc.2011.4.2.133
Zaglool SS, Zickri MB, Abd El Aziz DH, Mabrouk D, Metwally HG. Effect of stem cell therapy on amiodarone induced fibrosing interstitial lung disease in albino rat. Int J Stem Cells. 2011 Nov;4(2):133-42. doi: 10.15283/ijsc.2011.4.2.133. PMID: 24298346; PMCID: PMC3840964.
Copy Download .nbib Format: NLM
Pre-injury beta blocker use does not affect the hyperdynamic response in older trauma patients.

Journal of emergencies, trauma, and shock

Evans DC, Khoo KM, Radulescu A, Cook CH, Gerlach AT, Papadimos TJ, Steinberg SM, Stawicki SP, Eiferman DS.
PMID: 25400393
J Emerg Trauma Shock. 2014 Oct;7(4):305-9. doi: 10.4103/0974-2700.142766.

PURPOSE: Trauma dogma dictates that the physiologic response to injury is blunted by beta-blockers and other cardiac medications. We sought to determine how the pre-injury cardiac medication profile influences admission physiology and post-injury outcomes.MATERIALS AND METHODS: Trauma patients older...

Cite
Evans DC, Khoo KM, Radulescu A, et al. Pre-injury beta blocker use does not affect the hyperdynamic response in older trauma patients. J Emerg Trauma Shock. 2014;7(4):305-9doi: 10.4103/0974-2700.142766.
Evans, D. C., Khoo, K. M., Radulescu, A., Cook, C. H., Gerlach, A. T., Papadimos, T. J., Steinberg, S. M., Stawicki, S. P., & Eiferman, D. S. (2014). Pre-injury beta blocker use does not affect the hyperdynamic response in older trauma patients. Journal of emergencies, trauma, and shock, 7(4), 305-9. https://doi.org/10.4103/0974-2700.142766
Evans, David C, et al. "Pre-injury beta blocker use does not affect the hyperdynamic response in older trauma patients." Journal of emergencies, trauma, and shock vol. 7,4 (2014): 305-9. doi: https://doi.org/10.4103/0974-2700.142766
Evans DC, Khoo KM, Radulescu A, Cook CH, Gerlach AT, Papadimos TJ, Steinberg SM, Stawicki SP, Eiferman DS. Pre-injury beta blocker use does not affect the hyperdynamic response in older trauma patients. J Emerg Trauma Shock. 2014 Oct;7(4):305-9. doi: 10.4103/0974-2700.142766. PMID: 25400393; PMCID: PMC4231268.
Copy Download .nbib Format: NLM
Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patients.

International journal of endocrinology

Uchida T, Kasai T, Takagi A, Sekita G, Komiya K, Takeno K, Shigihara N, Shimada K, Miyauchi K, Fujitani Y, Daida H, Watada H.
PMID: 25053942
Int J Endocrinol. 2014;2014:534904. doi: 10.1155/2014/534904. Epub 2014 Jun 25.

Amiodarone is a widely used agent for life-threatening arrhythmias. Although amiodarone-induced thyrotoxicosis (AIT) is a major adverse effect that can cause recurrence of arrhythmias and exacerbation of heart failure, risk factors for AIT among amiodarone-treated Japanese patients have not...

Cite
Uchida T, Kasai T, Takagi A, et al. Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patients. Int J Endocrinol. 2014;2014:534904doi: 10.1155/2014/534904.
Uchida, T., Kasai, T., Takagi, A., Sekita, G., Komiya, K., Takeno, K., Shigihara, N., Shimada, K., Miyauchi, K., Fujitani, Y., Daida, H., & Watada, H. (2014). Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patients. International journal of endocrinology, 2014534904. https://doi.org/10.1155/2014/534904
Uchida, Toyoyoshi, et al. "Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patients." International journal of endocrinology vol. 2014 (2014): 534904. doi: https://doi.org/10.1155/2014/534904
Uchida T, Kasai T, Takagi A, Sekita G, Komiya K, Takeno K, Shigihara N, Shimada K, Miyauchi K, Fujitani Y, Daida H, Watada H. Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patients. Int J Endocrinol. 2014;2014:534904. doi: 10.1155/2014/534904. Epub 2014 Jun 25. PMID: 25053942; PMCID: PMC4099344.
Copy Download .nbib Format: NLM
Drugs in breastfeeding.

Australian prescriber

Hotham N, Hotham E.
PMID: 26648652
Aust Prescr. 2015 Oct;38(5):156-9. doi: 10.18773/austprescr.2015.056. Epub 2015 Oct 01.

Most commonly used drugs are relatively safe for breastfed babies. The dose received via milk is generally small and much less than the known safe doses of the same drug given directly to neonates and infants. Drugs contraindicated during...

Cite
Hotham N, Hotham E. Drugs in breastfeeding. Aust Prescr. 2015;38(5):156-9doi: 10.18773/austprescr.2015.056.
Hotham, N., & Hotham, E. (2015). Drugs in breastfeeding. Australian prescriber, 38(5), 156-9. https://doi.org/10.18773/austprescr.2015.056
Hotham, Neil, and Hotham, Elizabeth. "Drugs in breastfeeding." Australian prescriber vol. 38,5 (2015): 156-9. doi: https://doi.org/10.18773/austprescr.2015.056
Hotham N, Hotham E. Drugs in breastfeeding. Aust Prescr. 2015 Oct;38(5):156-9. doi: 10.18773/austprescr.2015.056. Epub 2015 Oct 01. PMID: 26648652; PMCID: PMC4657301.
Copy Download .nbib Format: NLM
Characteristics of corneal phospholipidosis induced by topical ocular application of chloroquine and amiodarone in rabbits.

Journal of toxicologic pathology

Yamagiwa Y, Haranosono Y, Nemoto S, Atsumi I, Kurata M, Kito G, Hatakeyama H, Koizumi H, Sakaki H.
PMID: 28458451
J Toxicol Pathol. 2017 Apr;30(2):135-143. doi: 10.1293/tox.2016-0003. Epub 2016 Nov 27.

Several cationic-amphiphilic drugs such as chloroquine and amiodarone are known to induce phospholipidosis in the cornea by systemic administration. However, the characteristics of ophthalmological and pathological changes when phospholipidosis-inducing drugs are topically applied have not been well studied. This...

Cite
Yamagiwa Y, Haranosono Y, Nemoto S, et al. Characteristics of corneal phospholipidosis induced by topical ocular application of chloroquine and amiodarone in rabbits. J Toxicol Pathol. 2016;30(2):135-143doi: 10.1293/tox.2016-0003.
Yamagiwa, Y., Haranosono, Y., Nemoto, S., Atsumi, I., Kurata, M., Kito, G., Hatakeyama, H., Koizumi, H., & Sakaki, H. (2017). Characteristics of corneal phospholipidosis induced by topical ocular application of chloroquine and amiodarone in rabbits. Journal of toxicologic pathology, 30(2), 135-143. https://doi.org/10.1293/tox.2016-0003
Yamagiwa, Yoshinori, et al. "Characteristics of corneal phospholipidosis induced by topical ocular application of chloroquine and amiodarone in rabbits." Journal of toxicologic pathology vol. 30,2 (2017): 135-143. doi: https://doi.org/10.1293/tox.2016-0003
Yamagiwa Y, Haranosono Y, Nemoto S, Atsumi I, Kurata M, Kito G, Hatakeyama H, Koizumi H, Sakaki H. Characteristics of corneal phospholipidosis induced by topical ocular application of chloroquine and amiodarone in rabbits. J Toxicol Pathol. 2017 Apr;30(2):135-143. doi: 10.1293/tox.2016-0003. Epub 2016 Nov 27. PMID: 28458451; PMCID: PMC5406592.
Copy Download .nbib Format: NLM
The blue child - amiodarone-induced blue-gray skin syndrome and pulmonary mass in a child.

Clinical case reports

Paech C, Wagner F, Suchowerskyj P, Weidenbach M.
PMID: 27014451
Clin Case Rep. 2016 Feb 08;4(3):276-8. doi: 10.1002/ccr3.483. eCollection 2016 Mar.

Adverse effects of amiodarone are rarely seen in pediatric patients, but may occur if amiodarone is applied for long-term treatment. Two rather rare phenomena are blue-gray skin pigmentation and pulmonary mass. They represent important differential diagnoses from more common...

Cite
Paech C, Wagner F, Suchowerskyj P, et al. The blue child - amiodarone-induced blue-gray skin syndrome and pulmonary mass in a child. Clin Case Rep. 2016;4(3):276-8doi: 10.1002/ccr3.483.
Paech, C., Wagner, F., Suchowerskyj, P., & Weidenbach, M. (2016). The blue child - amiodarone-induced blue-gray skin syndrome and pulmonary mass in a child. Clinical case reports, 4(3), 276-8. https://doi.org/10.1002/ccr3.483
Paech, Christian, et al. "The blue child - amiodarone-induced blue-gray skin syndrome and pulmonary mass in a child." Clinical case reports vol. 4,3 (2016): 276-8. doi: https://doi.org/10.1002/ccr3.483
Paech C, Wagner F, Suchowerskyj P, Weidenbach M. The blue child - amiodarone-induced blue-gray skin syndrome and pulmonary mass in a child. Clin Case Rep. 2016 Feb 08;4(3):276-8. doi: 10.1002/ccr3.483. eCollection 2016 Mar. PMID: 27014451; PMCID: PMC4771858.
Copy Download .nbib Format: NLM
The effect of long-term amiodarone administration on myocardial fibrosis and evolution of left ventricular remodeling in a porcine model of ischemic cardiomyopathy.

SpringerPlus

Zagorianou A, Marougkas M, Drakos SG, Diakos N, Konstantopoulos P, Perrea DN, Anastasiou-Nana M, Malliaras K.
PMID: 27652141
Springerplus. 2016 Sep 15;5(1):1568. doi: 10.1186/s40064-016-3249-3. eCollection 2016.

Amiodarone is effective in suppressing arrhythmias in heart failure patients. We investigated the effect of long-term amiodarone administration on myocardial fibrosis and left ventricular (LV) remodeling in a porcine model of ischemic cardiomyopathy. Eighteen infarcted farm pigs were randomized...

Cite
Zagorianou A, Marougkas M, Drakos SG, et al. The effect of long-term amiodarone administration on myocardial fibrosis and evolution of left ventricular remodeling in a porcine model of ischemic cardiomyopathy. Springerplus. 2016;5(1):1568doi: 10.1186/s40064-016-3249-3.
Zagorianou, A., Marougkas, M., Drakos, S. G., Diakos, N., Konstantopoulos, P., Perrea, D. N., Anastasiou-Nana, M., & Malliaras, K. (2016). The effect of long-term amiodarone administration on myocardial fibrosis and evolution of left ventricular remodeling in a porcine model of ischemic cardiomyopathy. SpringerPlus, 5(1), 1568. https://doi.org/10.1186/s40064-016-3249-3
Zagorianou, Anastasia, et al. "The effect of long-term amiodarone administration on myocardial fibrosis and evolution of left ventricular remodeling in a porcine model of ischemic cardiomyopathy." SpringerPlus vol. 5,1 (2016): 1568. doi: https://doi.org/10.1186/s40064-016-3249-3
Zagorianou A, Marougkas M, Drakos SG, Diakos N, Konstantopoulos P, Perrea DN, Anastasiou-Nana M, Malliaras K. The effect of long-term amiodarone administration on myocardial fibrosis and evolution of left ventricular remodeling in a porcine model of ischemic cardiomyopathy. Springerplus. 2016 Sep 15;5(1):1568. doi: 10.1186/s40064-016-3249-3. eCollection 2016. PMID: 27652141; PMCID: PMC5023647.
Copy Download .nbib Format: NLM
Factors affecting the quality of anticoagulation with warfarin: experience of one cardiac centre.

Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery

Ciurus T, Cichocka-Radwan A, Lelonek M.
PMID: 26855650
Kardiochir Torakochirurgia Pol. 2015 Dec;12(4):334-40. doi: 10.5114/kitp.2015.56784. Epub 2015 Dec 30.

INTRODUCTION: The risk of complications in anticoagulation therapy can be reduced by maximising the percentage of time spent by the patient in the optimal therapeutic range (TTR). However, little is known about the predictors of anticoagulation control. The aim...

Cite
Ciurus T, Cichocka-Radwan A, Lelonek M. Factors affecting the quality of anticoagulation with warfarin: experience of one cardiac centre. Kardiochir Torakochirurgia Pol. 2015;12(4):334-40doi: 10.5114/kitp.2015.56784.
Ciurus, T., Cichocka-Radwan, A., & Lelonek, M. (2015). Factors affecting the quality of anticoagulation with warfarin: experience of one cardiac centre. Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery, 12(4), 334-40. https://doi.org/10.5114/kitp.2015.56784
Ciurus, Tomasz, et al. "Factors affecting the quality of anticoagulation with warfarin: experience of one cardiac centre." Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery vol. 12,4 (2015): 334-40. doi: https://doi.org/10.5114/kitp.2015.56784
Ciurus T, Cichocka-Radwan A, Lelonek M. Factors affecting the quality of anticoagulation with warfarin: experience of one cardiac centre. Kardiochir Torakochirurgia Pol. 2015 Dec;12(4):334-40. doi: 10.5114/kitp.2015.56784. Epub 2015 Dec 30. PMID: 26855650; PMCID: PMC4735535.
Copy Download .nbib Format: NLM
Intraoperative loading dose of amiodarone for prophylaxis against atrial fibrillation after valvular heart surgery.

Anesthesia, essays and researches

Amr YM, Elmistekawy EM, Hammad AA.
PMID: 25885238
Anesth Essays Res. 2010 Jul-Dec;4(2):96-101. doi: 10.4103/0259-1162.73515.

OBJECTIVE: Benefit of amiodarone in restoring sinus rhythm (SR) after cardiac surgery was concluded in previous studies that used different protocols for giving amiodarone. The purpose of this study was to assess the use of single parenteral intraoperative loading...

Cite
Amr YM, Elmistekawy EM, Hammad AA. Intraoperative loading dose of amiodarone for prophylaxis against atrial fibrillation after valvular heart surgery. Anesth Essays Res. 2010;4(2):96-101doi: 10.4103/0259-1162.73515.
Amr, Y. M., Elmistekawy, E. M., & Hammad, A. A. (2010). Intraoperative loading dose of amiodarone for prophylaxis against atrial fibrillation after valvular heart surgery. Anesthesia, essays and researches, 4(2), 96-101. https://doi.org/10.4103/0259-1162.73515
Amr, Yasser Mohamed, et al. "Intraoperative loading dose of amiodarone for prophylaxis against atrial fibrillation after valvular heart surgery." Anesthesia, essays and researches vol. 4,2 (2010): 96-101. doi: https://doi.org/10.4103/0259-1162.73515
Amr YM, Elmistekawy EM, Hammad AA. Intraoperative loading dose of amiodarone for prophylaxis against atrial fibrillation after valvular heart surgery. Anesth Essays Res. 2010 Jul-Dec;4(2):96-101. doi: 10.4103/0259-1162.73515. PMID: 25885238; PMCID: PMC4173353.
Copy Download .nbib Format: NLM
Narrow Complex Ventricular Tachycardia.

Cureus

Sundhu M, Yildiz M, Gul S, Syed M, Azher I, Mosteller R.
PMID: 28875096
Cureus. 2017 Jul 04;9(7):e1423. doi: 10.7759/cureus.1423.

Myocardial infarctions are frequently complicated by tachyarrhythmias, which commonly have wide QRS complexes (QRS duration > 120 milliseconds). Many published criteria exist to help differentiate between ventricular and supraventricular mechanisms. We present a case of a 61-year-old male with...

Cite
Sundhu M, Yildiz M, Gul S, et al. Narrow Complex Ventricular Tachycardia. Cureus. 2017;9(7):e1423doi: 10.7759/cureus.1423.
Sundhu, M., Yildiz, M., Gul, S., Syed, M., Azher, I., & Mosteller, R. (2017). Narrow Complex Ventricular Tachycardia. Cureus, 9(7), e1423. https://doi.org/10.7759/cureus.1423
Sundhu, Murtaza, et al. "Narrow Complex Ventricular Tachycardia." Cureus vol. 9,7 (2017): e1423. doi: https://doi.org/10.7759/cureus.1423
Sundhu M, Yildiz M, Gul S, Syed M, Azher I, Mosteller R. Narrow Complex Ventricular Tachycardia. Cureus. 2017 Jul 04;9(7):e1423. doi: 10.7759/cureus.1423. PMID: 28875096; PMCID: PMC5580969.
Copy Download .nbib Format: NLM
Atrial Fibrillation in Acute Coronary Syndrome.

Journal of atrial fibrillation

Rubenstein JC, Cinquegrani MP, Wright J.
PMID: 28496750
J Atr Fibrillation. 2012 Jun 15;5(1):551. doi: 10.4022/jafib.551. eCollection 2012.

Atrial fibrillation (AF) is a common cardiac arrhythmia occurring in an estimated 2.7 to 6.1 million people in the United States. The risk factors for the development of AF are very similar to those for developing coronary artery disease,...

Cite
Rubenstein JC, Cinquegrani MP, Wright J. Atrial Fibrillation in Acute Coronary Syndrome. J Atr Fibrillation. 2012;5(1):551doi: 10.4022/jafib.551.
Rubenstein, J. C., Cinquegrani, M. P., & Wright, J. (2012). Atrial Fibrillation in Acute Coronary Syndrome. Journal of atrial fibrillation, 5(1), 551. https://doi.org/10.4022/jafib.551
Rubenstein, Jason C, et al. "Atrial Fibrillation in Acute Coronary Syndrome." Journal of atrial fibrillation vol. 5,1 (2012): 551. doi: https://doi.org/10.4022/jafib.551
Rubenstein JC, Cinquegrani MP, Wright J. Atrial Fibrillation in Acute Coronary Syndrome. J Atr Fibrillation. 2012 Jun 15;5(1):551. doi: 10.4022/jafib.551. eCollection 2012. PMID: 28496750; PMCID: PMC5153085.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 845 entries